← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fairbanks Pharmaceuticals
Concord, MA
$2,023,609
Total funding
2
Grants
Funding over time
peak $920.2K · FY2016–19$1M$750K$500K$250K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$2,023,609 · 2
By mechanism
R44$1,831,508 · 1
R43$192,101 · 1
Investigators at Fairbanks Pharmaceuticals
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity$920,248
R44 · FY2018 · DK
Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity$911,260
R44 · FY2019 · DK
Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity$192,101
R43 · FY2016 · DK